{ "cik": 1631574, "cik_padded": "0001631574", "entityName": "Wave Life Sciences Ltd.", "fiscal_years": [ { "accn": "0001193125-26-073472", "filed": "2026-02-26", "fiscal_year": 2025, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 718000.0, "cash": 602068000.0, "eps_diluted": -1.21, "free_cash_flow": -188211000.0, "net_income": -204378000.0, "operating_cash_flow": -187493000.0, "operating_income": -215383000.0, "revenue": 42727000.0, "stockholders_equity": 518357000.0, "total_assets": 638499000.0, "total_liabilities": 112268000.0 }, "period_end": "2025-12-31", "ratio_units": { "leverage": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.21658432315952134, "revenue_growth_yoy": -0.6054828165684845, "roa_avg2y": -0.4125906171962217, "roa_period_end": -0.3200913392190121, "roe_avg2y": -0.5615767607491428, "roe_period_end": -0.3942803897699847 } }, { "accn": "0001193125-26-073472", "filed": "2026-02-26", "fiscal_year": 2024, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 938000.0, "cash": 302078000.0, "eps_diluted": -0.7, "free_cash_flow": -151964000.0, "net_income": -97008000.0, "operating_cash_flow": -151026000.0, "operating_income": -110403000.0, "revenue": 108302000.0, "stockholders_equity": 209515000.0, "total_assets": 352207000.0, "total_liabilities": 134818000.0 }, "period_end": "2024-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.6434766007207121, "net_margin": -0.895717530608853, "operating_margin": -1.0193994570737384, "revenue_growth_yoy": -0.04415515643616787, "roa_avg2y": -0.30935843713525824, "roa_period_end": -0.27542893809606284, "roe_avg2y": -0.778727247185374, "roe_period_end": -0.46301219483091904 } }, { "accn": "0001193125-26-073472", "filed": "2026-02-26", "fiscal_year": 2023, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 1115000.0, "cash": 200351000.0, "eps_diluted": -0.54, "free_cash_flow": -20546000.0, "net_income": -57513000.0, "operating_cash_flow": -19431000.0, "operating_income": -67996000.0, "revenue": 113305000.0, "stockholders_equity": 39630000.0, "total_assets": 274949000.0, "total_liabilities": 227445000.0 }, "period_end": "2023-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 5.739212717638153, "net_margin": -0.5075945456952473, "operating_margin": -0.6001147345659944, "revenue_growth_yoy": 30.050972869279253, "roa_avg2y": -0.2730036669158745, "roa_period_end": -0.20917697463893303, "roe_avg2y": 21.063175242629555, "roe_period_end": -1.4512490537471612 } }, { "accn": "0001193125-26-073472", "filed": "2026-02-26", "fiscal_year": 2022, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 1361000.0, "cash": 88497000.0, "eps_diluted": -2.05, "free_cash_flow": -129142000.0, "net_income": -161823000.0, "operating_cash_flow": -127781000.0, "operating_income": -162720000.0, "revenue": 3649000.0, "stockholders_equity": -45091000.0, "total_assets": 146386000.0, "total_liabilities": 183603000.0 }, "period_end": "2022-12-31", "ratio_units": { "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio" }, "ratios": { "revenue_growth_yoy": -0.9109217849819353, "roa_avg2y": -0.9158245918849552, "roa_period_end": -1.1054540734769718, "roe_avg2y": 25.700468514253952 } }, { "accn": "0000950170-25-031322", "filed": "2025-03-04", "fiscal_year": 2021, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 560000.0, "cash": 150564000.0, "eps_diluted": -2.36, "free_cash_flow": -89553000.0, "net_income": -122245000.0, "operating_cash_flow": -88993000.0, "operating_income": -127016000.0, "revenue": 40964000.0, "stockholders_equity": 32498000.0, "total_assets": 207007000.0, "total_liabilities": 166635000.0 }, "period_end": "2021-12-31", "ratio_units": { "leverage": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 5.127546310542187, "revenue_growth_yoy": 1.0403446730089156, "roa_avg2y": -0.5028123682505733, "roa_period_end": -0.5905355857531388, "roe_avg2y": -2.120909816440543, "roe_period_end": -3.761616099452274 } }, { "accn": "0001564590-22-008414", "filed": "2023-03-23", "fiscal_year": 2020, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 1338000.0, "cash": 184497000.0, "free_cash_flow": -117320000.0, "net_income": -149910000.0, "operating_cash_flow": -115982000.0, "operating_income": -153377000.0, "revenue": 20077000.0, "stockholders_equity": 82778000.0, "total_assets": 279238000.0, "total_liabilities": 188586000.0 }, "period_end": "2020-12-31", "ratio_units": { "leverage": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 2.2782140182174007, "revenue_growth_yoy": 0.2561471563536257, "roa_avg2y": -0.5320787665398375, "roa_period_end": -0.5368538665940882, "roe_avg2y": -2.0464132141150775, "roe_period_end": -1.8109884268767065 } }, { "accn": "0001564590-22-008414", "filed": "2022-03-03", "fiscal_year": 2019, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 3918000.0, "cash": 147161000.0, "free_cash_flow": -192149000.0, "net_income": -193638000.0, "operating_cash_flow": -188231000.0, "operating_income": -208317000.0, "revenue": 15983000.0, "stockholders_equity": 63732000.0, "total_assets": 284250000.0, "total_liabilities": 212644000.0 }, "period_end": "2019-12-31", "ratio_units": { "leverage": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 3.3365342371179314, "revenue_growth_yoy": 0.10885250450950465, "roa_avg2y": -0.6674985780520174, "roa_period_end": -0.6812242744063325, "roe_avg2y": -2.8251823752553253, "roe_period_end": -3.038316701186217 } }, { "accn": "0001564590-21-010718", "filed": "2021-03-04", "fiscal_year": 2018, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 9938000.0, "cash": 174819000.0, "free_cash_flow": -32800000.0, "net_income": -146653000.0, "operating_cash_flow": -22862000.0, "operating_income": -159523000.0, "revenue": 14414000.0, "stockholders_equity": 73348000.0, "total_assets": 295940000.0, "total_liabilities": 214718000.0 }, "period_end": "2018-12-31", "ratio_units": { "leverage": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 2.927387249822763, "revenue_growth_yoy": 2.702543025944002, "roa_avg2y": -0.613889569114012, "roa_period_end": -0.49554977360275726, "roe_avg2y": -1.3772950534847246, "roe_period_end": -1.9994137536129137 } }, { "accn": "0001564590-20-007972", "filed": "2020-03-02", "fiscal_year": 2017, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 18887000.0, "cash": 142503000.0, "free_cash_flow": -102558000.0, "net_income": -101980000.0, "operating_cash_flow": -83671000.0, "operating_income": -102391000.0, "revenue": 3893000.0, "stockholders_equity": 139610000.0, "total_assets": 181843000.0, "total_liabilities": 34359000.0 }, "period_end": "2017-12-31", "ratio_units": { "leverage": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.2461070123916625, "revenue_growth_yoy": 2.5650183150183152, "roa_avg2y": -0.5883676518949731, "roa_period_end": -0.5608134489642164, "roe_avg2y": -0.7437986390191602, "roe_period_end": -0.7304634338514433 } }, { "accn": "0001564590-20-007972", "filed": "2020-03-02", "fiscal_year": 2016, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 5567000.0, "cash": 150293000.0, "free_cash_flow": -37492000.0, "net_income": -55660000.0, "operating_cash_flow": -31925000.0, "operating_income": -55720000.0, "revenue": 1092000.0, "stockholders_equity": 134604000.0, "total_assets": 164811000.0, "total_liabilities": 22074000.0 }, "period_end": "2016-12-31", "ratio_units": { "leverage": "ratio", "roa_period_end": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.16399215476508872, "roa_period_end": -0.33772017644453345, "roe_period_end": -0.4135092567828593 } } ], "latest_filing": { "accn": "0001193125-26-073472", "filed": "2026-02-26", "form": "10-K" }, "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.", "schema_version": "1", "sic": "2834", "sic_description": "Pharmaceutical Preparations", "source_urls": { "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001631574.json", "sec_submissions": "https://data.sec.gov/submissions/CIK0001631574.json" }, "ticker": "WVE" }